Press

2016-02-19

Interim Report for Kancera AB (publ) Q4 2015, January 1 – December 31, 2015

The period January to December 2015 and the fourth quarter 2015 in brief R&D expenses for the period amounted to SEK 20.4m (SEK 13.7m) of which the fourth quarter constituted SEK 8.3m (SEK 4.1m). Following EU’s approval of Kancera’s...

Read More
2015-11-20

Interim Report for Kancera AB (publ) Q3 2015. January 1 – September 30, 2015.

The period January to September 2015 and the third quarter 2015 in brief R&D expenses for the period amounted to SEK 12.1m (SEK 9.6m) of which the third quarter constituted SEK 3.2m (SEK 2.7m). Operating income for the period...

Read More
2015-08-21

Interim Report for Kancera AB (publ) Q2 2015, January 1 – June 30, 2015

The period January to June 2014 and the second quarter 2015 in brief R&D expenses for the period amounted to SEK 8.8m (SEK 6.9m) of which the second quarter constituted SEK 4.6m (SEK 3.4m). Operating income for the period...

Read More
2015-05-22

Interim Report for Kancera AB (publ) Q1 2015 January 1 – March 31, 2015

In 2013 Kancera changed from the RFR2 regulations, applicable to companies in groups, to BFN ́s complementary regulation K3. The full year report and consolidated accounts fulfill the requirements of Nasdaq First North for the accounting of Kancera AB....

Read More
2015-02-20

Full Year Report for Kancera AB (publ) Q4 2014 January 1 – December 31, 2014

In 2013 Kancera changed from the RFR2 regulations, applicable to companies in groups, to BFN ́s complementary regulation K3. The full year report and consolidated accounts fulfill the requirements of Nasdaq First North for the accounting of Kancera AB....

Read More
2014-11-21

Interim Report for Kancera AB (publ) Q3 2014

January 1 - September 30, 2014. All figures from the first quarter 2013 relate only to Kancera AB as a consequence of the liquidation of the subsidiary iNovacia AB in the beginning of 2013. In connection with this Kancera...

Read More
2014-08-22

Interim Report for Kancera AB (publ) Q2 2014

January 1 - June 30, 2014 All figures from the first quarter 2013 relate only to Kancera AB as a consequence of the liquidation of the subsidiary iNovacia AB in the beginning of 2013. In connection with this Kancera...

Read More
2014-05-23

Interim Report for Kancera AB (publ) Q1 2014

All figures from the first quarter 2013 relate only to Kancera AB as a consequence of the liquidation of the subsidiary iNovacia AB in the beginning of 2013. Therefore there are no consolidated accounts for the Kancera Group produced...

Read More
2014-02-21

Full Year Report for Kancera AB (publ) 2013 January 1 – December 31, 2013

All figures from the first quarter 2013 relate only to Kancera AB as a consequence of the liquidation of the subsidiary iNovacia AB in the beginning of 2013. Therefore there are no consolidated accounts for the Kancera Group produced...

Read More
2013-11-08

Interim Report for Kancera AB (publ) Q3 2013

All figures from the first quarter 2013 relate only to Kancera AB as a consequence of the liquidation of the subsidiary iNovacia AB in the beginning of 2013. Therefore there are no consolidated accounts for the Kancera Group produced...

Read More